Postmarketing Safety Concerns With FDA Black Box Warning Monoclonal Antibodies: A Pharmacovigilance Study Based on the FDA Adverse Event Reporting System Database. - Kalaivani K; Chandrasekaran S; Rajendran SD; Munishwararaj V; Vijayakumar TM (Journal of patient safety, 2026)